Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.

Researchers at St. Jude Children’s Research Hospital identified a panel of 27 serum proteins that accurately predicted ...

Moleculin Biotech, Inc., (Moleculin or the Company), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it has ...

Moleculin Biotech (MBRX) has received a Notice of Intent to Grant for the European patent application titled, “Method of Reconstituting ...

Such grant will enhance the global exclusivity of Annamycin with the potential to be a next generation, non-cardiotoxic treatment for certain cancers. When issued, the patent claims will cover ...

Cancer and cardiovascular diseases (CVDs) share common risk factors, and treatments for cancer have the potential to increase ...

Key opinion leaders explore approaches to dose modifications or treatment pauses due to side effects, including examples ...

LAMELLIBRANCHIA are difficult to narcotize and then to fix without subsequent contraction of the tissues. It has been found that propylene phenoxetol can be used with considerable success to ...

Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Department of Anatomy, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, ...

Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease ...

Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Science, Jilin University, 2699 Qianjin Street, Changchun 130012, China Edmond H. Fischer Signal ...

Chest radiotherapy (XRT) plays a crucial role in the treatment of a multitude of cancers including breast, lung, esophageal, and lymphoma. Although XRT enhances cancer survival rates, it may also ...